Latest Asx Trading News

Page 2 of 34
Amaero Ltd has obtained Federal Court approval to re-domicile to Delaware via schemes exchanging Australian shares and options for US HoldCo equivalents, marking a major structural shift.
Victor Sage
Victor Sage
10 June 2026
Antilles Gold’s Cuban joint venture Minera La Victoria has been hit with US sanctions, prompting a suspension of the company’s direct involvement and halting trading of its shares and options.
Maxwell Dee
Maxwell Dee
10 June 2026
The Supreme Court of Western Australia has approved Genesis Minerals’ acquisition of Magnetic Resources, setting a clear timetable for scheme implementation and ASX trading suspension.
Maxwell Dee
Maxwell Dee
9 June 2026
Hartshead Resources held a pivotal scheme meeting on 8 June 2026 to approve ACAM GP Limited’s acquisition offer, featuring a 133% premium and unanimous board support. The outcome now hinges on final court approval.
Maxwell Dee
Maxwell Dee
9 June 2026
The Supreme Court of New South Wales has approved schemes of arrangement that transfer Nova Minerals' ownership to a new US holding company, with ASX trading set to suspend immediately.
Maxwell Dee
Maxwell Dee
3 June 2026
Opthea Limited resumes ASX trading as it pivots to develop OPT-302 for lymphangioleiomyomatosis, outlining a disciplined 18-month staged clinical program backed by A$31.2 million in cash.
Ada Torres
Ada Torres
3 June 2026
Corporate Travel Management reports progress on UK customer remediation with funding plans underway and final agreements near completion. The company maintains strong client retention above 97% and aims to release audited FY25 and reviewed 1H26 financials by end of June, eyeing a swift return to ASX trading.
Victor Sage
Victor Sage
1 June 2026
Nova Minerals shareholders and Nasdaq warrantholders overwhelmingly approved schemes to restructure the company under a new US holding entity, pending final court approval.
Maxwell Dee
Maxwell Dee
1 June 2026
Elanor Investors Group has called off its planned acquisition of Singapore-based Firmus Capital due to prolonged regulatory delays, while reaffirming its $125 million recapitalisation with Rockworth Capital Partners and seeking ASX trading reinstatement.
Eva Park
Eva Park
29 May 2026
Nexalis Therapeutics has locked in a $53 million non-dilutive funding facility with Point8 Capital, replacing its previous lender and supporting three clinical programs targeting breakthrough cancer pain, panic disorder, and treatment-resistant depression.
Ada Torres
Ada Torres
28 May 2026
Straker Limited resumes ASX trading after suspending shares due to transaction anomalies at its US subsidiary. The company maintains normal operations while cooperating with US authorities.
Sophie Babbage
Sophie Babbage
27 May 2026
5E Advanced Materials has requested suspension of its shares from ASX trading to enable its removal from the official list, marking a significant shift in its market presence.
Maxwell Dee
Maxwell Dee
26 May 2026